Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON39987Phase 4Active, not recruiting
Phase 4, randomised, double-blind trial in Nicotine withdrawal comparing Nicotine patch with Placebo / blinding plaster control (2 arms). Primary endpoint: 30-day mortality. Started Jul 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON39987.